These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7144293)

  • 41. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
    Mateos MV; Hernández JM; Hernández MT; Gutiérrez NC; Palomera L; Fuertes M; Garcia-Sanchez P; Lahuerta JJ; de la Rubia J; Terol MJ; Sureda A; Bargay J; Ribas P; Alegre A; de Arriba F; Oriol A; Carrera D; García-Laraña J; García-Sanz R; Bladé J; Prósper F; Mateo G; Esseltine DL; van de Velde H; San Miguel JF
    Haematologica; 2008 Apr; 93(4):560-5. PubMed ID: 18322252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure.
    Souliotis VL; Dimopoulos MA; Episkopou HG; Kyrtopoulos SA; Sfikakis PP
    DNA Repair (Amst); 2006 Aug; 5(8):972-85. PubMed ID: 16781199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma.
    Moreau P; Milpied N; Mahé B; Juge-Morineau N; Rapp MJ; Bataille R; Harousseau JL
    Bone Marrow Transplant; 1999 May; 23(10):1003-6. PubMed ID: 10373065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of intravenous melphalan in the treatment of Kahler's disease].
    Balmes A; Dauverchain J; Othoniel J; Mandin A; Chavanette F
    Presse Med (1893); 1971 May; 7(23):1072. PubMed ID: 5577947
    [No Abstract]   [Full Text] [Related]  

  • 45. [Sweet's syndrome and multiple myeloma].
    Borbujo J; de Lucas R; Manzano R; Casado M
    Med Clin (Barc); 1996 Mar; 106(9):354-5. PubMed ID: 8667704
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute leukemia secondary to multiple myeloma.
    de Gramont A; Rioux E; Shields C
    Can Med Assoc J; 1983 Sep; 129(6):534, 536. PubMed ID: 6576845
    [No Abstract]   [Full Text] [Related]  

  • 47. Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.
    Berenson JR; Yang HH; Vescio RA; Nassir Y; Mapes R; Lee SP; Wilson J; Yellin O; Morrison B; Hilger J; Swift R
    Ann Hematol; 2008 Aug; 87(8):623-31. PubMed ID: 18463870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
    Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P
    Haematologica; 2002 Aug; 87(8):846-50. PubMed ID: 12161361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic progress--review XII. Treatment of multiple myeloma.
    Oakley JE; Franklin IM
    J Clin Hosp Pharm; 1984 Mar; 9(1):15-20. PubMed ID: 6371060
    [No Abstract]   [Full Text] [Related]  

  • 50. [Malignant lymphoma with c-myc gene rearrangement in a patient receiving long-term treatment for multiple myeloma].
    Ohnishi H; Kamimura T; Gondo H; Okamura T; Niho Y; Yao T
    Rinsho Ketsueki; 1999 Dec; 40(12):1265-70. PubMed ID: 10658480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma.
    Buxhofer-Ausch V; Ruckser R; Kier P; Habertheuer KH; Zelenka P; Tatzreiter G; Ausch C; Schmid I; Hruby W; Reiner-Concin A; Sebesta C; Ogris E; Hinterberger-Fischer M; Hinterberger W
    Eur J Haematol; 2004 Aug; 73(2):143-6. PubMed ID: 15245515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in peripheral blood monocyte number in patients with multiple myeloma treated with melphalan].
    Mendek-Czajkowska E; Rostkowska J; Mariańska B; Sawicki Z; Maj S
    Acta Haematol Pol; 1984; 15(3-4):119-24. PubMed ID: 6537120
    [No Abstract]   [Full Text] [Related]  

  • 53. Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.
    Palumbo A; Triolo S; Baldini L; Callea V; Capaldi A; De Stefano V; Grasso M; Liberati M; Lotesoriere C; Marcenò R; Marmont F; Musto P; Petrucci MT; Spriano M; Pileri A; Boccadoro M
    Haematologica; 2000 May; 85(5):508-13. PubMed ID: 10800168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Melphalan kinetics in hyperthermic isolation perfusion of the extremities.
    Loos U; Musch E; Rauschecker H; Willenbrock C
    J Chemother; 1989 Jul; 1(4 Suppl):1246-7. PubMed ID: 16312851
    [No Abstract]   [Full Text] [Related]  

  • 55. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
    Hulin C; Facon T; Rodon P; Pegourie B; Benboubker L; Doyen C; Dib M; Guillerm G; Salles B; Eschard JP; Lenain P; Casassus P; Azaïs I; Decaux O; Garderet L; Mathiot C; Fontan J; Lafon I; Virion JM; Moreau P
    J Clin Oncol; 2009 Aug; 27(22):3664-70. PubMed ID: 19451428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy of multiple myeloma].
    La Verde G; Pulsoni A; Petrucci MT; Mandelli F
    Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Gynecomastia appearing during myeloma: role of melphalan?].
    Cohen JD; Fulpin J; Chouc PY; Jeandel P
    Presse Med; 2000 Nov; 29(35):1936. PubMed ID: 11244624
    [No Abstract]   [Full Text] [Related]  

  • 60. Pleural and pericardial effusion as the first sign of multiple myeloma.
    André M; Ponsonnaille J; Kemeny JL; Filaire M; Travade P; Aumaitre O
    Ann Med Interne (Paris); 1999 Sep; 150(5):443-5. PubMed ID: 10544757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.